4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0000899243-20-027692
Director bought 1,315 shares at $19.00 ($24,985)
- Director acquired 14,679 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Salter Malcolm Director | 2020-10-06 | Conversion | +11,856 | 11,856 | D | ||
| Salter Malcolm Director | 2020-10-06 | Conversion | +2,823 | 14,679 | D | ||
| Salter Malcolm Director | 2020-10-06 | Purchase | +1,315 | $19.00 | $24,985 | 15,994 | D |
| Derivatives | |||||||
| Salter Malcolm Director | 2020-10-06 | Conversion · Series A Preferred Stock | −100,000 | 0 | D | ||
| Salter Malcolm Director | 2020-10-06 | Conversion · Series B Preferred Stock | −23,809 | 0 | D | ||
| Open-market purchases · 1,315 sh · avg $19.00 · $24,985 | |||||||
Loading xslF345X03/doc4.xml…